ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,871Medicare Part D Prescriptions Filled, Including Refills

Rank: 96 out of 783

$894K Total Retail Price of All Prescriptions

Rank: 68 out of 783

796 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 796 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 796 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 12,477 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
AMLODIPINE BESYLATE 547 470 1 5
LEVOTHYROXINE SODIUM 508 472 2 1
PRAVASTATIN SODIUM 479 440 3 14
SIMVASTATIN 353 325 4 3
FUROSEMIDE 336 276 5 7
LISINOPRIL 326 286 6 4
HYDROCHLOROTHIAZIDE 310 288 7 12
METFORMIN HCL 281 258 8 8
ATENOLOL 257 251 9 17
OMEPRAZOLE 246 194 10 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 245 224 11 33
HYDROCODONE-ACETAMINOPHEN 227 168 S3 12 2
METOPROLOL SUCCINATE 220 215 13 13
CARVEDILOL 198 175 14 21
ATORVASTATIN CALCIUM 180 169 15 11
GABAPENTIN 178 146 16 15
ZOLPIDEM TARTRATE 174 152 17 23
WARFARIN SODIUM 172 167 18 10
SERTRALINE HCL 164 149 19 22
POTASSIUM CHLORIDE 156 148 20 16
METOPROLOL TARTRATE 151 144 21 9
DONEPEZIL HCL 150 146 22 24
LOSARTAN-HYDROCHLOROTHIAZIDE 141 112 23 53
GLIPIZIDE 128 113 24 71
OXYBUTYNIN CHLORIDE 128 125 24 96
MELOXICAM 128 106 24 37
ALLOPURINOL 126 99 27 31
ALENDRONATE SODIUM 122 119 28 25
PANTOPRAZOLE SODIUM 120 110 29 30
TRAMADOL HCL 115 103 30 20
TAMSULOSIN HCL 113 107 31 26
FENOFIBRATE 112 111 32 66
NEXIUM 111 92 33 28
CELEBREX 111 111 33 93
PAROXETINE HCL 108 84 35 69
PREDNISONE 106 95 36 36
DIOVAN HCT 104 95 37 94
LOSARTAN POTASSIUM 99 92 38 18
PLAVIX 97 90 39 51
ISOSORBIDE MONONITRATE ER 96 85 40 40
DICLOFENAC SODIUM 93 83 41 139
KLOR-CON M20 92 91 42 48
AMITRIPTYLINE HCL 92 69 R 42 77
TERAZOSIN HCL 87 80 44 130
DIGOXIN 85 85 45 61
GLYBURIDE 83 75 R 46 111
CLOPIDOGREL 82 76 47 29
FLUTICASONE PROPIONATE 80 77 48 46
ZETIA 76 73 49 80
LOVASTATIN 74 71 50 58
HYDRALAZINE HCL 74 70 50 78
SYNTHROID 73 73 52 47
DIOVAN 71 71 53 49
PEN NEEDLE 67 58 54 103
RANITIDINE HCL 65 65 55 44
AZITHROMYCIN 65 59 55 41
HUMULIN 70-30 65 40 55 211
INSULIN SYRINGE 65 62 55 82
SINGULAIR 64 54 59 90
ADVAIR DISKUS 64 64 59 50
TRICOR 62 50 61 134
TRAZODONE HCL 60 45 62 39
PROAIR HFA 56 40 63 56
POLYETHYLENE GLYCOL 3350 56 48 63 43
BENICAR 56 55 63 182
CITALOPRAM HBR 54 47 66 19
LIPITOR 53 53 67 114
ENALAPRIL MALEATE 51 44 68 68
PREMARIN 51 51 R 68 176
LEVOXYL 50 50 70 150
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.